Literature DB >> 23842562

GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients.

Peter Humaidan, Lise H Thomsen, Birgit Alsbjerg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23842562     DOI： 10.1093/humrep/det287

Source DB:  PubMed          Journal:  Hum Reprod        ISSN： 0268-1161            Impact factor:   6.918


× No keyword cloud information.
  11 in total

Review 1.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

2.  Fertility preservation in reproductive-age women facing gonadotoxic treatments.

Authors:  J Roberts; R Ronn; N Tallon; H Holzer
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

3.  Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.

Authors:  Ali Abbara; Channa N Jayasena; Georgios Christopoulos; Shakunthala Narayanaswamy; Chioma Izzi-Engbeaya; Gurjinder M K Nijher; Alexander N Comninos; Deborah Peters; Adam Buckley; Risheka Ratnasabapathy; Julia K Prague; Rehan Salim; Stuart A Lavery; Stephen R Bloom; Matyas Szigeti; Deborah A Ashby; Geoffrey H Trew; Waljit S Dhillo
Journal:  J Clin Endocrinol Metab       Date:  2015-07-20       Impact factor: 5.958

4.  Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study.

Authors:  Céline Pirard; Ernest Loumaye; Pascale Laurent; Christine Wyns
Journal:  Int J Endocrinol       Date:  2015-04-05       Impact factor: 3.257

Review 5.  Pharmaceutical options for triggering of final oocyte maturation in ART.

Authors:  Juan Carlos Castillo; Peter Humaidan; Rafael Bernabéu
Journal:  Biomed Res Int       Date:  2014-07-15       Impact factor: 3.411

6.  Is It Possible to Prevent Ovarian Hyperstimulation Syndrome by Gonadotropin-Releasing Hormone Agonist Triggering and Modified Luteal Support in Patients With Polycystic Ovarian Morphology?

Authors:  Ali Sami Gurbuz; Ruya Deveer; Mert Kucuk; Necati Ozcimen; Dilek Incesu; Sezen Koseoglu
Journal:  J Clin Med Res       Date:  2016-03-20

Review 7.  GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article.

Authors:  Ashraf Alyasin; Shayesteh Mehdinejadiani; Marzieh Ghasemi
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-09

8.  Comparison of GnRH agonist and hCG for priming in vitro maturation cycles in cancer patients undergoing urgent fertility preservation.

Authors:  Hady El Hachem; Charlotte Sonigo; Julie Benard; Marion Presse; Christophe Sifer; Nathalie Sermondade; Michael Grynberg
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

Review 9.  Gonadotropin-releasing hormone agonist for ovulation trigger - OHSS prevention and use of modified luteal phase support for fresh embryo transfer.

Authors:  Juan Carlos Castillo; Thor Haahr; María Martínez-Moya; Peter Humaidan
Journal:  Ups J Med Sci       Date:  2020-05-04       Impact factor: 2.384

10.  A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.

Authors:  Ali Abbara; Sophie Clarke; Rumana Islam; Julia K Prague; Alexander N Comninos; Shakunthala Narayanaswamy; Deborah Papadopoulou; Rachel Roberts; Chioma Izzi-Engbeaya; Risheka Ratnasabapathy; Alexander Nesbitt; Sunitha Vimalesvaran; Rehan Salim; Stuart A Lavery; Stephen R Bloom; Les Huson; Geoffrey H Trew; Waljit S Dhillo
Journal:  Hum Reprod       Date:  2017-09-01       Impact factor: 6.918
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.